3/30 $RXRXAccum, how long will it take? Funnymentals will determine if/when this will take off. Something something great stonk, moreover better accum pattern
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−34.64 MXN
−9.67 B MXN
1.23 B MXN
305.89 M
About Recursion Pharmaceuticals, Inc.
Sector
Industry
CEO
Chistopher C. Gibson
Website
Headquarters
Salt Lake City
Founded
2013
FIGI
BBG01S8283L6
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
$42 TARGET $RXRX BUY NOW!The triple bottom chart pattern usually emerges after an extended downtrend with bears dominating the market. While the first bottom might reflect regular price fluctuations, the second bottom signals that the bulls are gathering strength and gearing up for a potential reversal. The third bottom dem
RXRX SL-$7,45 TP-$9,55Technical Analysis:
Rounded bottom accumulation and compression
Increase in bullish volume
Crossover of EMA 20 and EMA 200
DON'T WALK, RUN!!RXRX is at the heart of AI ADVANCEMENT in biotech. Pioneers in bringing new drugs to market faster and cheaper. One of the largest biological and chemical datasets built for drug discovery and development. Meet BIOHIVE - the world's largest pharmaceutical supercomputer.
Entry (starter position) 8.
RxRxDefinitely possible to reach 6.90 before earnings... but i think not the likely scenario.
I think the likely scenario is we close above 7.90 for a few days then get a cross followed by some real upward movement.
Any real news that is positive could send this upward at any point now.
I believe
RXRX in a channel between 0.382 fib & golden pocketThere's a channel between the 382 fib and golden pocket on RXRX. I drew 2 trendlines going up and down. It looks like we'll see a continuation of this fib channel but with the possibility of creating new support above the 382 fib line.
Why we played RXRX on Jan 17Good doji set up on the chart
Market was trending upwards, so we wanted to take a risk on a stock and betting in the upward direction.
RXRX Jan 7th 2025GT + FIB + previous high.
Fibonacci Retracement Bounce:
The price is bouncing near the 0.5 Fibonacci retracement level, which is a common support zone in an uptrend. This suggests buyers are stepping in at this level.
Risk-to-Reward Ratio:
The trade setup shows a favorable risk-to-reward ratio (
$RXRX - Believe we are at the start of Wave 5I've been trying to wrap my head around the movement with the $9.50 spike recently from an Elliot Wave Theory and fibs perspective. The closest I've gotten to making it all make sense is that we just had a crazy wave 4 correction and this low of $7.24 works out fib wise with wave 1. We also have 4 d
four bottoms make huge trendThis is a clear long signal with 4 bottoms and long enough flat. As now AI concept changed from hardware to software, there is huge potential up trend, right now.
Stoploss 7.00
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of RXRX is 124.00 MXN — it hasn't changed in the past 24 hours. Watch RECURSION PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange RECURSION PHARMACEUTICALS INC stocks are traded under the ticker RXRX.
RXRX stock hasn't changed in a week, the last month showed zero change in price, over the last year RECURSION PHARMACEUTICALS INC has showed a −38.00% decrease.
We've gathered analysts' opinions on RECURSION PHARMACEUTICALS INC future price: according to them, RXRX price has a max estimate of 225.11 MXN and a min estimate of 122.79 MXN. Watch RXRX chart and read a more detailed RECURSION PHARMACEUTICALS INC stock forecast: see what analysts think of RECURSION PHARMACEUTICALS INC and suggest that you do with its stocks.
RXRX reached its all-time high on Feb 18, 2025 with the price of 219.00 MXN, and its all-time low was 124.00 MXN and was reached on Mar 11, 2025. View more price dynamics on RXRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RXRX stock is 0.00% volatile and has beta coefficient of 3.96. Track RECURSION PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is RECURSION PHARMACEUTICALS INC there?
Today RECURSION PHARMACEUTICALS INC has the market capitalization of 43.60 B, it has increased by 6.53% over the last week.
Yes, you can track RECURSION PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
RECURSION PHARMACEUTICALS INC is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
RXRX earnings for the last quarter are −11.05 MXN per share, whereas the estimation was −8.58 MXN resulting in a −28.82% surprise. The estimated earnings for the next quarter are −10.57 MXN per share. See more details about RECURSION PHARMACEUTICALS INC earnings.
RECURSION PHARMACEUTICALS INC revenue for the last quarter amounts to 94.05 M MXN, despite the estimated figure of 319.29 M MXN. In the next quarter, revenue is expected to reach 306.97 M MXN.
RXRX net income for the last quarter is −3.73 B MXN, while the quarter before that showed −1.89 B MXN of net income which accounts for −97.52% change. Track more RECURSION PHARMACEUTICALS INC financial stats to get the full picture.
No, RXRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RECURSION PHARMACEUTICALS INC EBITDA is −9.22 B MXN, and current EBITDA margin is −752.07%. See more stats in RECURSION PHARMACEUTICALS INC financial statements.
Like other stocks, RXRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RECURSION PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.